Key points for development of immunotherapy for cancer using T cell defined tumor antigens

Yutaka Kawakami

Research output: Contribution to journalArticle

Abstract

New immunotherapies using cancer antigens recognized by T-cells have recently been developed and a variety of phase I clinical trals has been conducted in the US and Europe. An anti-tumor effect has already been observed in some protocols. However, many questions still remain to establish effective immunotherapies for cancer. Key points which were raised in the research on immunotherapies against melanoma are discussed in this article.

Original languageEnglish
Pages (from-to)429-433
Number of pages5
JournalBiotherapy
Volume13
Issue number5
Publication statusPublished - 1999

Fingerprint

Neoplasm Antigens
Immunotherapy
T-Lymphocytes
Neoplasms
Melanoma
Antigens
Research

Keywords

  • Cancer antigens
  • Dendritic cells
  • Immunotherapy
  • Peptides
  • T-cells

ASJC Scopus subject areas

  • Cancer Research
  • Immunology and Allergy

Cite this

Key points for development of immunotherapy for cancer using T cell defined tumor antigens. / Kawakami, Yutaka.

In: Biotherapy, Vol. 13, No. 5, 1999, p. 429-433.

Research output: Contribution to journalArticle

@article{f82c1149c84540aaacd12058a5cb8ec5,
title = "Key points for development of immunotherapy for cancer using T cell defined tumor antigens",
abstract = "New immunotherapies using cancer antigens recognized by T-cells have recently been developed and a variety of phase I clinical trals has been conducted in the US and Europe. An anti-tumor effect has already been observed in some protocols. However, many questions still remain to establish effective immunotherapies for cancer. Key points which were raised in the research on immunotherapies against melanoma are discussed in this article.",
keywords = "Cancer antigens, Dendritic cells, Immunotherapy, Peptides, T-cells",
author = "Yutaka Kawakami",
year = "1999",
language = "English",
volume = "13",
pages = "429--433",
journal = "Biotherapy",
issn = "0914-2223",
publisher = "Japanese Society for Cancer Chemotherapy",
number = "5",

}

TY - JOUR

T1 - Key points for development of immunotherapy for cancer using T cell defined tumor antigens

AU - Kawakami, Yutaka

PY - 1999

Y1 - 1999

N2 - New immunotherapies using cancer antigens recognized by T-cells have recently been developed and a variety of phase I clinical trals has been conducted in the US and Europe. An anti-tumor effect has already been observed in some protocols. However, many questions still remain to establish effective immunotherapies for cancer. Key points which were raised in the research on immunotherapies against melanoma are discussed in this article.

AB - New immunotherapies using cancer antigens recognized by T-cells have recently been developed and a variety of phase I clinical trals has been conducted in the US and Europe. An anti-tumor effect has already been observed in some protocols. However, many questions still remain to establish effective immunotherapies for cancer. Key points which were raised in the research on immunotherapies against melanoma are discussed in this article.

KW - Cancer antigens

KW - Dendritic cells

KW - Immunotherapy

KW - Peptides

KW - T-cells

UR - http://www.scopus.com/inward/record.url?scp=0033003661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033003661&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033003661

VL - 13

SP - 429

EP - 433

JO - Biotherapy

JF - Biotherapy

SN - 0914-2223

IS - 5

ER -